Thermo Fisher Scientific reported total revenue of $11.99 billion for the quarter ended June 2026, up 10.5% from the prior-year period, with international segments showing mixed results against analyst estimates. Revenue from Other regions reached $430 million, or 3.6% of the total, exceeding the consensus estimate of $368.27 million by 16.76%. Asia-Pacific contributed $2.1 billion, or 17.5% of total revenue, falling 1.87% short of the $2.14 billion forecast. Europe generated $3.31 billion, or 27.6% of total revenue, surpassing the $3 billion consensus by 10.46%. For the current quarter, Wall Street expects total revenue of $11.91 billion, with Other regions, Asia-Pacific, and Europe projected to contribute 3.2%, 18.4%, and 25.7% respectively.
Thermo Fisher Scientific IncTotal revenue beat estimates, with Europe and Other regions exceeding consensus, indicating strong performance.